普雷斯蒂奇(PBH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PBH 普雷斯蒂奇

盘前交易 06-08 08:27:43 EDT

47.18

+1.74

+3.83%

最高47.57	最低46.23	成交量50.74万
今开46.23	昨收45.44	日振幅2.95%
总市值22.32亿	流通市值22.32亿	总股本4,732万
成交额2,389万	换手率1.07%	流通股本4,732万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PBH","market":"US","secType":"STK","nameCN":"普雷斯蒂奇","latestPrice":47.18,"timestamp":1780689600000,"preClose":45.44,"halted":0,"volume":507412,"delay":0,"changeRate":0.03829225352112681,"floatShares":47318730,"shares":47318730,"eps":3.91,"marketStatus":"盘前交易","change":1.74,"latestTime":"06-08 08:27:43 EDT","open":46.23,"high":47.57,"low":46.23,"amount":23886029,"amplitude":0.029489,"askPrice":54.27,"askSize":100,"bidPrice":39.59,"bidSize":100,"shortable":3,"etf":0,"ttmEps":3.91,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780925400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1108011600000,"exchange":"NYSE","adjPreClose":47.18,"postHourTrading":{"tag":"盘后","latestPrice":47.18,"preClose":47.18,"latestTime":"19:37 EDT","volume":19989,"amount":943081.84,"timestamp":1780702648297,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7516176250890159,"impliedVol":0.2841,"impliedVolPercentile":0.696},"requestUrl":"/m/hq/s/PBH","defaultTab":"news","newsList":[{"id":"1156655839","title":"异动解读 | 奥本海默下调评级叠加业绩疲软，普雷斯蒂奇盘中大跌16.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156655839","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156655839?lang=zh_cn&edition=full","pubTime":"2026-05-14 21:58","pubTimestamp":1778767101,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇今日盘中股价大跌16.04%，引起了市场的广泛关注。消息面上，此次股价大幅下挫主要受到两方面因素影响。首先，知名投行奥本海默将普雷斯蒂奇的股票评级从“跑赢大盘”下调至“中性”，这一分析师评级的下调直接打击了市场信心。评级调整与不及预期的业绩共同构成了股价承压的主要原因。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159165152","title":"异动解读 | 奥本海默下调评级叠加业绩疲软，普雷斯蒂奇盘前大跌6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159165152","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159165152?lang=zh_cn&edition=full","pubTime":"2026-05-14 21:07","pubTimestamp":1778764026,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇今日盘前股价大跌6.79%，引起了市场的广泛关注。消息面上，奥本海默将普雷斯蒂奇的股票评级从“跑赢大盘”下调至“中性”，这一分析师评级的下调对市场情绪产生了直接影响。此外，公司此前公布的财务数据显示业绩疲软，其第四季度营收为2.816亿美元，略低于分析师预期；2026财年营收为10.9亿美元，较上年同期下降4.3%；财年每股收益为3.91美元，也低于上年同期的4.29美元。分析师评级调整与不及预期的业绩共同构成了股价承压的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128454968","title":"异动解读 | 年度业绩疲软，普雷斯蒂奇夜盘大跌7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128454968","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128454968?lang=zh_cn&edition=full","pubTime":"2026-05-14 14:51","pubTimestamp":1778741495,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇（PBH）今日夜盘股价大跌7.14%，引起了市场的广泛关注。消息面上，公司公布的第四季度营收为2.816亿美元，略低于分析师平均预期的约2.82亿美元。此外，2026财年营收为10.9亿美元，较上年同期下降4.3%；财年每股收益为3.91美元，也低于上年同期的4.29美元。业绩表现疲软是导致股价下跌的主要原因。公司同时宣布将以约1.5亿美元收购澳大利亚护肤公司LaCorium Health，该交易预计将于2027财年第二季度完成。然而，市场当前更关注其财务数据的下滑，截至上一交易日收盘，该公司股价年内已累计下跌约16%。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145435697","title":"异动解读 | 年度业绩疲软，普雷斯蒂奇盘后大跌6.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=1145435697","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145435697?lang=zh_cn&edition=full","pubTime":"2026-05-14 06:23","pubTimestamp":1778711024,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇（PBH）今日盘后股价大跌6.39%，引起了市场的广泛关注。消息面上，公司公布的第四季度营收为2.816亿美元，略低于分析师平均预期的约2.82亿美元。此外，2026财年营收为10.9亿美元，较上年同期下降4.3%；财年每股收益为3.91美元，也低于上年同期的4.29美元。业绩表现疲软是导致股价下跌的主要原因。公司同时宣布将以约1.5亿美元收购澳大利亚护肤公司LaCorium Health，该交易预计将于2027财年第二季度完成。然而，市场当前更关注其财务数据的下滑，截至上一交易日收盘，该公司股价年内已累计下跌约16%。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187740321","title":"普雷斯蒂奇消费者健康公司：预计中期年营收复合增长率约10%，每股收益复合增长率约8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187740321","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187740321?lang=zh_cn&edition=full","pubTime":"2026-05-14 04:38","pubTimestamp":1778704696,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇消费者健康公司（Prestige Consumer Healthcare）发布中期增长预期，预计将实现年营收约10%的复合增长率。与此同时，公司每股收益的增长步伐也相当稳健，预计复合年增长率将达到8%左右。这一展望勾勒出公司未来几年的财务发展路径，展现了管理层对业务持续扩张与盈利能力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131566939","title":"普雷斯蒂奇消费者健康：Lacorium业务全面整合后，预计息税折旧及摊销前利润约达1200万美元，包含协同效应收益","url":"https://stock-news.laohu8.com/highlight/detail?id=1131566939","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131566939?lang=zh_cn&edition=full","pubTime":"2026-05-14 04:37","pubTimestamp":1778704648,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇消费者健康公司旗下Lacorium业务，预计在全面整合后，将产生约1200万美元的息税折旧及摊销前利润，其中包含了协同效应带来的收益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141260594","title":"普雷斯蒂奇消费者健康公司公布2026财年业绩，并宣布收购Lacorium Health","url":"https://stock-news.laohu8.com/highlight/detail?id=1141260594","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141260594?lang=zh_cn&edition=full","pubTime":"2026-05-14 04:33","pubTimestamp":1778704393,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇消费者健康公司公布了其2026财年的财务业绩，同时宣布了一项重大收购——将Lacorium Health纳入旗下。这一举措标志着公司在扩大其健康产品组合和增强市场竞争力方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135762259","title":"财报前瞻｜普雷斯蒂奇本季度营收预计小幅增长，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1135762259","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135762259?lang=zh_cn&edition=full","pubTime":"2026-05-07 00:00","pubTimestamp":1778083226,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇将于2026年05月13日发布最新季度财报，市场关注利润率修复与品牌组合表现对指引的影响。市场一致预期本季度普雷斯蒂奇营收为2.95亿美元，同比增长1.86%；EBIT为9,825.12万美元，同比增长2.49%；调整后每股收益为1.39美元，同比增长7.04%。上季度普雷斯蒂奇营收为2.83亿美元，同比下降2.37%；毛利率为56.38%；归属母公司的净利润为4,669.60万美元，净利率为16.47%；调整后每股收益为1.14美元，同比下降6.56%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜普雷斯蒂奇本季度营收预计小幅增长，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159507684","title":"普雷斯蒂奇消费健康公司斥资10.45亿美元收购Breathe Right等品牌 税后净额9亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159507684","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159507684?lang=zh_cn&edition=full","pubTime":"2026-03-20 18:16","pubTimestamp":1774001773,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇消费健康公司（Prestige Consumer Healthcare Inc）宣布将以10.45亿美元收购Breathe Right及其他品牌组合。在考虑税收优惠后，该项交易净额约为9亿美元。此次收购将显著增强普雷斯蒂奇在消费健康领域的品牌矩阵与市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149288587","title":"普雷斯蒂奇消费者医疗保健公司宣布达成协议，收购鼻腔贴片领域领导者Breathe Right®","url":"https://stock-news.laohu8.com/highlight/detail?id=1149288587","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149288587?lang=zh_cn&edition=full","pubTime":"2026-03-20 18:15","pubTimestamp":1774001713,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇消费者医疗保健公司已正式签署协议，将收购鼻腔贴片市场的领军品牌Breathe Right®。此次收购标志着该公司在拓展非处方健康产品组合方面迈出关键一步，旨在强化其在鼻腔护理细分市场的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181242523","title":"财报前瞻｜普雷斯蒂奇本季度营收预计降1.87%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1181242523","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181242523?lang=zh_cn&edition=full","pubTime":"2026-01-29 11:17","pubTimestamp":1769656678,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇将在2026年02月05日发布最新季度财报，市场关注收入和盈利指标的同比走弱与费用控制节奏带来的利润弹性。市场一致预期显示，本季度普雷斯蒂奇总收入预计为2.81亿美元，同比下降1.87%；调整后每股收益预计为1.14美元，同比下降1.81%；息税前利润预计为8,424.50万美元，同比下降4.04%。上季度普雷斯蒂奇营收为2.74亿美元，同比下降3.41%；毛利率56.21%；归属母公司净利润为4,221.10万美元，环比下降11.07%；净利率15.40%；调整后每股收益为1.07美元，同比下降1.84%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜普雷斯蒂奇本季度营收预计降1.87%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164687044","title":"Prestige Wealth 2024年上半年每股收益为-0.055美元，较去年同期的0.003美元有所下降；收入为497,629美元，较去年同期的312,964美元有所上升","url":"https://stock-news.laohu8.com/highlight/detail?id=1164687044","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164687044?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:31","pubTimestamp":1739482262,"startTime":"0","endTime":"0","summary":"Prestige Wealth 2024年上半年每股收益为-0.055美元，较去年同期的0.003美元有所下降；收入为497,629美元，较去年同期的312,964美元有所上升以上内容来自Benzinga Earnings专栏，原文如下：Prestige Wealth H1 2024 EPS $(0.055) Down From $0.003 YoY; Revenue $497.629K Up From $312.964K YoY","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBH","PWM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511784095","title":"奥本海默：维持Prestige Consumer(PBH.US)评级，由优于大市调整至优于大市评级, 目标价由87.00美元调整至93.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511784095","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511784095?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:06","pubTimestamp":1739466398,"startTime":"0","endTime":"0","summary":"奥本海默：维持Prestige Consumer(PBH.US)评级，由优于大市调整至优于大市评级, 目标价由87.00美元调整至93.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14010648150561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509254778","title":"加拿大投资银行集团：维持Prestige Consumer(PBH.US)评级，由买入调整至买入评级, 目标价由93.00美元调整至100.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509254778","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509254778?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:04","pubTimestamp":1738955052,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Prestige Consumer(PBH.US)评级，由买入调整至买入评级, 目标价由93.00美元调整至100.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/08030448031698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133143496","title":"异动解读 | 普雷斯蒂奇第三季度业绩超预期,盘中股价大涨6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133143496","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133143496?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:50","pubTimestamp":1738853402,"startTime":"0","endTime":"0","summary":"普雷斯蒂奇公司(PBH)今日盘中股价大涨6.31%,引起市场广泛关注。该公司盘中股价表现与其季度業绩表现息息相关。\n\n普雷斯蒂奇公司近期公布了截至2024年12月31日的第三财季报告。财报显示,普雷斯蒂奇第三季度调整后每股收益为1.22美元,超过了分析师平均预期的1.16美元,同比去年同期也有15%的增长。营收方面,该公司第三财季营收为2.9032亿美元,也超过了2.8648亿美元的预期,同比增长2.7%。\n\n普雷斯蒂奇第三季度业绩亮眼,盈利和营收表现均超出市场预期,这令投资者对公司长期前景抱有信心,从而推动股价在盘中出现大涨。股价大涨说明市场对普雷斯蒂奇良好的财务表现予以正面评价。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145457806","title":"Prestige Consumer第三季度调整后每股收益$1.22 超过预期$1.16，销售额$2.9032亿 超过预期$2.8648亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1145457806","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145457806?lang=zh_cn&edition=full","pubTime":"2025-02-06 19:06","pubTimestamp":1738839995,"startTime":"0","endTime":"0","summary":"Prestige Consumer报告季度调整后每股收益为$1.22，比分析师一致预期的$1.16高出5.17%。公司报告季度销售额为$2.9032亿，超过分析师一致预期的$2.8648亿，超出1.34%。这比去年同期的销售额$2.8274亿增长了2.68%。以上内容来自Benzinga Earnings专栏，原文如下：Prestige Consumer  reported quarterly adjusted earnings of $1.22 per share which beat the analyst consensus estimate of $1.16 by 5.17 percent. This is a 15.09 percent increase over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $290.32 million which beat the analyst consensus estimate ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Prestige Consumer第三季度调整后每股收益$1.22 超过预期$1.16，销售额$2.9032亿 超过预期$2.8648亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484510479","title":"普雷斯蒂奇2024财年第三财季实现净利润54.38百万美元，同比增加1.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484510479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484510479?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:00","pubTimestamp":1731772809,"startTime":"0","endTime":"0","summary":"11月17日，普雷斯蒂奇公布财报，公告显示公司2024财年第三财季净利润为54.38百万美元，同比增加1.53%；其中营业收入为2.84亿美元，同比减少0.70%，每股基本收益为1.10美元。从资产负债表来看，普雷斯蒂奇总负债15.85亿美元，其中短期债务2.65百万美元，资产负债比为2.10，流动比率为3.57。机构评级：截至2024年11月17日，当前有6家机构对普雷斯蒂奇目标价做出预测，其中目标均价为87.83美元，其中最低目标价为81.00美元，最高目标价为95.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000019a23e049c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000019a23e049c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481985155","title":"普雷斯蒂奇盘中异动 早盘急速上涨5.16%报78.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481985155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481985155?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:40","pubTimestamp":1730904011,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时40分，普雷斯蒂奇股票出现异动，股价大幅上涨5.16%。截至发稿，该股报78.63美元/股，成交量6849股，换手率0.01%，振幅0.85%。普雷斯蒂奇股票所在的制药行业中，整体跌幅为0.49%。普雷斯蒂奇公司简介：Prestige Consumer Healthcare 是一家美国公司，向大众零售商、药店、便利店、超市和电子商务渠道分销品牌非处方保健和家居清洁产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622401198e40e4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622401198e40e4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2470033811","title":"美国OTC市场Eiger Biopharmaceuticals, Inc.盘中异动 早盘快速下跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470033811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470033811?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:18","pubTimestamp":1727450323,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时18分，美国OTC市场Eiger Biopharmaceuticals, Inc.股票出现异动，股价急速下跌5.88%。美国OTC市场Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。美国OTC市场Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231843ab66870c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231843ab66870c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4123","CHI","EIGRQ","HDV","BK4585","BK4007","BK4588","PBH","PL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2468508030","title":"美国OTC市场Eiger Biopharmaceuticals, Inc.（EIGRQ.us）盘中异动 急速下跌64.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468508030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468508030?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:16","pubTimestamp":1726755361,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时16分，美国OTC市场Eiger Biopharmaceuticals, Inc.股票出现波动，股价急速下挫64.71%。美国OTC市场Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。美国OTC市场Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192216019f0803d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192216019f0803d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4123","CHI","PBH","BK4585","BK4007","HDV","EIGRQ","PL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prestigebrands.com","stockEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.1313},{"period":"3month","weight":-0.2978},{"period":"6month","weight":-0.2243},{"period":"1year","weight":-0.4424},{"period":"ytd","weight":-0.2352}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prestige Consumer Healthcare Inc.于1996年在特拉华州注册成立。该公司从事非处方健康和个人护理产品的开发、制造、营销和分销，销售渠道覆盖北美（美国和加拿大）、澳大利亚及其他国际市场的综合超市、药品及药品批发、食品、一元店、便利店和会员店以及电子商务渠道。公司通过两个报告分部运营：北美非处方医疗保健和国际非处方医疗保健。","yearOnYearQuotes":[{"month":1,"riseRate":0.380952,"avgChangeRate":-0.025979},{"month":2,"riseRate":0.619048,"avgChangeRate":0.019416},{"month":3,"riseRate":0.636364,"avgChangeRate":0.020768},{"month":4,"riseRate":0.590909,"avgChangeRate":0.030471},{"month":5,"riseRate":0.5,"avgChangeRate":-0.007096},{"month":6,"riseRate":0.5,"avgChangeRate":0.020741},{"month":7,"riseRate":0.52381,"avgChangeRate":-0.012027},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.014475},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.004269},{"month":10,"riseRate":0.571429,"avgChangeRate":0.008492},{"month":11,"riseRate":0.619048,"avgChangeRate":0.035644},{"month":12,"riseRate":0.714286,"avgChangeRate":0.033181}],"exchange":"NYSE","name":"普雷斯蒂奇","nameEN":"Prestige"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"普雷斯蒂奇(PBH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供普雷斯蒂奇(PBH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"普雷斯蒂奇,PBH,普雷斯蒂奇股票,普雷斯蒂奇股票老虎,普雷斯蒂奇股票老虎国际,普雷斯蒂奇行情,普雷斯蒂奇股票行情,普雷斯蒂奇股价,普雷斯蒂奇股市,普雷斯蒂奇股票价格,普雷斯蒂奇股票交易,普雷斯蒂奇股票购买,普雷斯蒂奇股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"普雷斯蒂奇(PBH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供普雷斯蒂奇(PBH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}